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Summary
Objective: Establishment of a clonal bipotent chondroprogenitor cell line from adult mouse to provide a new tool for the elucidation of
chondrogenesis in adult animal.
Design: A clonal cell line CL-1 was established from tibia of adult mouse. Differentiation of CL-1 was characterized in monolayer culture.
Effects of growth factors (TGF-1, IGF-I, bFGF) and hormones (all trans retinoic acid, 1.25(OH)2D3, PTH (1-34)) on the growth and
differentiation of CL-1 were examined. Bipotency of CL-1 in vivo was examined by transplantation into SCID mice.
Results: CL-1 formed alcian blue (pH1.0) positive nodules spontaneously. The nodules were mineralized in the presence of ascorbic acid and
-glycerophosphate. CL-1 differentiated also into oil red O positive adipocytes spontaneously. CL-1 cells expressed specific genes of
chondrocytes (collagen type II, X, aggrecan) and adipocytes (PPAR-2, aP2). Hyaline cartilage and adipose tissue formation was observed
also in subcutaneously transplanted CL-1 cells into SCID mice. These data demonstrate that CL-1 has bipotency either in vitro or in vivo.
TGF-1 suppressed growth of CL-1 and induced dominant chondrogenesis accompanied with marked suppression of adipogenesis in 10%
FCS. IGF-I stimulated both growth (in 3% FCS) and differentiation of CL-1 into both lineages (in 10% FCS). 1.25(OH)2D3 and all trans
retinoic acid acted as negative regulators on proliferation and differentiation of CL-1 in 10% FCS.
Conclusions: CL-1 will be a useful tool for the understanding of chondrogenesis in adult animal. Furthermore, CL-1 can be also a powerful
tool for screening of the chondrogenic agent.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Chondrocytes play central roles in skeletal formation
through endochondral ossification and joint function
through articular cartilage1. It has been considered that
chondrocytes are derived from mesenchymal multipotent
stem cells, which also give rise to muscle, fat and bone2. In
recent studies, multipotent mesenchymal stem cells were
isolated from not only fetus3 but also bone marrow of adult
animal4. Application of autologous multipotent mesenchy-
mal stem cells for regeneration of injured tissue is devel-
oping5. In described mesenchymal lineages, master
regulatory genes have been identified in the differentiation
of committed progenitors like Runx2 for osteoblasts,
PPAR-2 for adipocytes, Myo-D for myocytes, and Sox9 for
chondrocytes, respectively6–9. On the other hand, regulat-
ory mechanisms of commitment in multipotent mesenchy-
mal cells into respective lineages are still unknown.
Understanding of these mechanisms in adult animal will
be greatly helpful to improve cartilage regeneration
technology.
Chondrogenic commitment of multipotent mesenchymal
cells has been studied with several cell lines derived from
fetus, neonate or adult transgenic animals10–13. These cell
lines require chondrogenic stimulators like dexametha-
sone, bone morphogenetic protein-2 (BMP-2) or insulin.
However, chondrogenic efficiency of these cell lines is not
high. In ATDC5, a cell line derived from a mouse embryonic
carcinoma cell line AT805, inductive dominant chondro-
genesis in the presence of insulin was reported14. How-
ever, since multipotency of this cell line is not reported, it
might not be appropriate for the elucidation of regulatory
mechanisms of chondrogenic commitment in multipotent
mesenchymal cells. In osteogenic lineage, BMP-2 induced
dominant osteogenic commitment accompanied with sup-
pression of myogenic commitment was reported in a rat
fetal cell line15. This example demonstrated that bipotent
cell line with inductive dominant commitment into specific
lineage could be a simple and useful tool for the elucidation
of the regulatory mechanisms of commitment in multi-
potent mesenchymal cells. As in the osteogenic lineage, a
bipotent chondrogenic cell line will provide a simple and
useful tool to understand the regulatory mechanisms of
chondrogenesis in multipotent mesenchymal cells. Since
different responsiveness between adult and fetal derived
cells to chondrogenesis regulating factors like PTH was
reported16, adult derived bipotent chondroprogenitor cell
line will provide a valuable tool to elucidate the regulatory
mechanisms of chondrogenesis in adult animal.
A bipotent cell line (CL-1) was established from tibia of
normal adult mouse, which differentiates into chondrocytes
and adipocytes. In this study, detailed characteristics of
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CL-1 including responses to growth factors and hormones
that regulate chondrogenesis were reported.
Materials and methods
CLONING AND CELL CULTURE
A proximal region of tibia was aseptically removed from a
cervically dislocated 5-week-old female C57BL/6Cr Slc
(SLC, Shizuoka, Japan) mouse. After soft tissue removal,
the proximal region was strongly rinsed in Dulbecco’s
phosphate buffered saline without Calcium and Magnesium
(PBS, ICN, Aurora, OH, U.S.A.) to remove bone marrow
cells. The proximal region was cultivated for 9 days in a
60-mm plastic dish (CORNING, Corning, NY, U.S.A.) in
-minimum essential medium (-MEM, GIBCO, Gland
Island, NY, U.S.A.) containing 10% FCS (Moregate,
Bulimba, Australia), 100 U/ml penicillinG (Banyu pharma-
ceutical Co., Tokyo, Japan), and 100 µg/ml streptomycin
sulphate (Meiji seika kaisha, Tokyo, Japan) at 37°C in 5%
CO2 in 95% humidified air. Then medium was changed
twice every 3 days. Three clusters of outgrown adherent
cells were picked up by 3×3 mm filter paper immersed in
0.05% trypsin (Sigma-Aldrich, St. Louis, MI, U.S.A.) and
cultivated on 24-well plates (CORNING) in 10% FCS/-
MEM. After 6 days, the filter paper was removed. Grown
cells were subcultured for 10 passages in 60-mm plastic
dishes (CORNING). Formation of mineralized nodules was
examined 5 weeks after culture in mineralization medium
composed of 10% FCS/-MEM containing 50 µg/ml
ascorbic acid and 10 mmol/l -glycero phosphate (Wako
pure chemical, Osaka, Japan). Mineralization of nodules
was examined with 0.3% alizarin red S (MERCK) staining.
One of the cells formed alizarin red S positive nodules, and
this parent cell line was subcultured until 16 passages. At
the 16th passage, limiting dilution cloning was performed.
Briefly, 100 µl of cell suspension (1 cell/ml) was plated into
96 wells plate (CORNING). Wells containing single cells
were checked microscopically. Six clones were grown, and
all of these clones formed alizarin red S positive nodules.
We selected a clone whose growth was the fastest within
the six clones, and named it CL-1.
TRANSMISSION ELECTRONMICROSCOPY
Ultrastructure of mineralized nodules was examined with
transmission electron microscopy. Cell layer cultivated in
mineralization medium for 28 days was prefixed with 2.5%
glutaraldehyde (TAAB, Berkshire, UK) in 0.1 mmol/l phos-
phate buffer (pH 7.4) for 3 h at 4°C. Post fixation by 1.0%
OsO4 (Nisshin EM, Tokyo, Japan) was followed for 15 min
at 4°C. The fixed cell layer was embedded in plastic (Quetol
812, Nissei Sangyo, Tokyo, Japan) after dehydration by
ethanol and acetone. Plastic was polymerized at 65°C,
overnight. Ultrathin sections were cut with a diamond knife
(Sumitomo electric, Osaka, Japan) and ultramicrotome
(2088 ULTRATOME V, LKB, Bromma, Sweden). Ultrathin
sections were stained with ulanyl acetate and lead citrate.
The samples were observed with a transmission electron
microscope (JEM 100S, JEOL, Tokyo, Japan).
ALCIAN BLUE STAINING
The cell layer of CL-1 was fixed with 4% paraformalde-
hyde (Wako pure chemical) for 1 h. After washing with
0.1 mol/l HCl (Wako pure chemical), it was stained with
alcian blue (pH 1.0, Wako pure chemical) overnight at room
temperature. For microscopy, nuclear staining was per-
formed with 0.3% nuclear fast red (MERCK). Stainability of
cell layers for alcian blue (alcian blue intensity) was
measured to quantify chondrogenesis in CL-1. Alcian blue
staining was performed as described above. After washing
three times with distilled water, alcian blue pigment was
extracted with 6 mol/l guanidine-HCl (Wako pure chemical)
for 5 h at room temperature. Absorbance of the extracts at
620 nm was measured with a microplate reader (Multiskan
MCC/340, Titertek instruments Inc., Huntsville, AL, U.S.A.).
OIL RED O STAINING
Cytoplasmic lipid droplets were detected by oil red O
staining. Fixed cell layers by 4% PFA were washed with
85% propylene glycol (Nacalai Tesque, Kyoto, Japan). After
washing with distilled water, cell layers were stained with
0.3% oil red O in 85% propylene glycol for 30 mins. After
washing with 85% propylene glycol and distilled water, it
was counterstained by 0.3% nuclear fast red. Double
staining with alcian blue (pH 1.0) counterstained by 0.3%
nuclear fast red was performed for microscopy.
ALKALINE PHOSPHATASE (ALP) CYTOCHEMISTRY
Five thousand CL-1 cells were plated on 24-well plates
(CORNING, day 0). Cells were fixed by ice-cold methanol
containing 9.99 % (v/v) formaline in 99.9% (v/v) and acetic
acid (0.01% v/v) on day 2 (as sparse phase) and day 7 (as
confluent phase). ALP activity was detected by naphtol
AS-BI (Sigma) as substrate and fast blue RR salt (Sigma)
as coupler. Counterstaining was performed by 0.3%
nuclear fast red.
CA AND INORGANIC PHOSPHORUS (PI) CONTENT
Five thousand CL-1 cells were plated on 60-mm plastic
dishes (CORNING). These were cultured in mineralization
medium or 10% FCS/-MEM for 28 days. Cells were
retrieved by a cell scraper (CORNING) after washing with
deionized water to remove Ca and Pi. Retrieved cell layers
were dried at 50°C, and placed in an oven at 800°C
(OPERUSER, Toyo seisakusyo, Tokyo, Japan) overnight.
Ash samples were solved in 300 µl of 6 mol/l HCl. Ca
content of these samples was measured using the O-CPC
method (Ca test Wako, Wako pure chemical). Pi content
was measured by p-methylphenol reduction method
(Phospha C-test Wako, Wako pure chemical).
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION
(RT-PCR)
Expression of molecular markers for chondrocytes,
adipocytes or osteoblasts was examined by RT-PCR. CL-1
cells were plated on 100 mm plastic dishes (2.5×103 cells/
cm2, Becton Dickinson) and cultivated in 10% FCS/-MEM
for 4 weeks. Total RNA was purified with the acid
guadinium-phenol-chloroform method (ISOGEN, Nippon
gene, Tokyo, Japan) at 1, 3, 7, 10 days after plating (from
sparse to subconfluent) and 1, 2, 3 weeks after confluence.
RT-PCR was performed with AMV RT-PCR kit (RNA PCR
Kit, TaKaRa, Tokyo, Japan) and PCR thermal cycler (Gene
Amp PCR system 9600, Perkin-Elmer Life Sciences,
Norwalk, CT, U.S.A.). Specific primers for collagen type I, II,
X, aggrecan, PPAR-2. aP2, Runx2, Osterix, and -actin
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were designed by a software program (Gene Works
Ver. 2.45, IntelliGenetics, Mountain View, CA, U.S.A.).
Nucleotide sequences were listed below.
Collagen type I: CCAGCGAAGAACTCATACAGC, AAGC
ACAGCCTTGTTGAAGC
Collagen type II: ACACAATCCATTGCGACC, AGATAGT
TCCTGTCTCCGCC
Collagen type X: CAGCTGGCATAGCAACTAAGG, GTG
GTTAGCACTGACAACG
Aggrecan: TGTTCAGTGGAACAGCAACC, AGATTGTT
CCACTGACGTCCACC
Ihh: AGATGGCCATCACTCAGAGG, ACTTGACAGAGC
AATGCACG
BMP-2: TGGAATGACTGGATCGTGG, GTACAACATGG
AGATTGCGC
PPAR-2: CTGATGCACTGCCTATGAGC, CATGAGGC
CTGTTGTAGAGC
aP2: ACGACAGGAAGGTGAAGAGC, ACTCTTGTGGA
AGTCACGCC
Runx2: CTTCGTCAGCATCCTATAGTTC, GAATGATGG
TGTTGACGCTGA
Osterix: GAAAGGAGGCACAAAGAAG, GGGGAGCAA
GTCAGATGG
-actin: CACCACACCTTCTACAA, CGGTCAGGATCTT
CATGA
One µg of the total RNA sample was treated with bovine
pancreas DNase I (DNaseI, TaKaRa) for 60 mins at 37°C to
digest genomic DNA contamination. DNaseI was inacti-
vated by 85°C incubation for 15 mins. Reverse transcrip-
tion was performed with random 9 mer as primers in the
cycle as follows: 30°C for 10 mins, 42°C for 25 mins, 95°C
for 10 min. All PCR was performed in the following cycle:
95°C for 1 min, 32 cycles of 94°C for 1 min, 57°C for 2 min,
and 72°C for 3 min followed by 1 cycle of 72°C for 7 min.
PCR products were analyzed by electrophoresis in 2%
agarose gels in 1×TAE buffer (Molecular biology certified
agarose, Bio-Rad laboratories, Hercules, CA, U.S.A.) con-
taining 0.07 µg/ml ethidium bromide (Wako pure chemical).
Detection of PCR products were detected by ultraviolet
transilluminator (FTM-26, UVP, Upland, CA, U.S.A.) and
photographed (Polaroid MP-4, Polapan T667, Polaroid,
Cambridge, MA, U.S.A.). Total RNA samples (digested by
DNaseI) without RT were also PCR amplified in the same
primers to check genomic contamination.
IMMUNOCYTOCHEMISTRY
CL-1 cells were plated on 4-well chamber slides (2.5×
103 cells/cm2, Nalge Nunc International) in 10%FCS/
-MEM for 4 weeks after confluence. Samples were fixed
with 4% paraformaldehyde, and detection of collagen type
I, II or X was performed using the avidin-biotin complex
method colored by diaminobenzidene (VECTASTAIN ABC
rabbit IgG kit, Vector, Burlingame, CA, U.S.A.). Primary
antibodies were the following: Anti-murine collagen type I
rabbit serum (×200 diluted, CHEMICON international Inc.,
Temecula, CA, U.S.A.), anti bovine collagen type II rabbit
serum (×200 diluted, LSL, Tokyo, Japan) and anti rat
collagen type X rabbit serum (×200 diluted, LSL). Normal
rabbit serum (×200 diluted) was used as a control serum.
TRANSPLANTATION OF CL-1 INTO SCID MICE
Five×106 of CL-1 cells were transplanted into back
subcutis in 6 week-old male SCID mice (Clea Japan Inc.,
Tokyo, Japan). As a control mesenchymal cell line without
specific phenotype, 5×106 cells of NIH3T3 (ATCC,
Rockville, MD, U.S.A.) were implanted into SCID mice. The
cell mass of transplanted CL-1 and NIH3T3 was removed
at 4 weeks after transplantation and fixed with neutral
buffered 20% formaldehyde (Wako pure chemical), and
paraffin sections of 4 µm thick were cut and stained with
1.0% toluidine blue pH 7.0 or haematoxylin-eosin
(MERCK).
GROWTH OF CL-1
CL-1 cells (500 cells/well) were plated on flat bottom
96-well plates (BD BioSciences, Billerica, MA, U.S.A.) in
-MEM containing 20% or 3% FCS. Three days after
plating, TGF-1 (AUSTRAL BIOLOGICALS, San Ramon,
CA, U.S.A.), PTH(1-34) (Peptide Institute, Osaka, Japan),
bFGF (BACHEM, Torrance, CA, U.S.A.), 1.25 (OH)2
vitamin D3 (VD3, BIOMOL, Plymouth Meeting, PA, U.S.A.)
or all trans retinoic acid (ATRA, Sigma-Aldrich) was added
to 20% FCS wells. IGF-I (CHEMICON) was added to 3%
FCS wells. After 24 h, cells were labeled with 0.1 µCi/well
3H-methyl-thymidine (Amersham, Tokyo, Japan) for a
further 6 h. Each dose was processed in triplicate. DNA
was retrieved on glass filters and radioactivity was counted
by a scintillation counter (Betaplate 1205-012, LKB).
EFFECT OF CYTOKINES AND HORMONES ON THE
DIFFERENTIATION OF CL-1
Effects of cytokines and hormones listed below on chon-
drogenesis were examined with alcian blue intensity. Five
thousand CL-1 cells/cm2 were plated on 24-well plates in
10%FCS/-MEM. At confluence, growth factors or hor-
mones were added respectively and cultured for 3 weeks
after confluence. Following factors were used: TGF-1,
IGF-I, Effect of VD3, ATRA, bFGF, and PTH (1-34). Plates
were retrieved every 7 days after addition of these factors
and alcian blue intensity was measured. Each dose was
examined in 6 wells. Cultures with the same treatment
were processed in 4-well chamber slides (Nalge Nunc
International), and differentiation was examined micro-
scopically by double staining of alcian blue (pH 1.0) and oil
red O counterstained by 0.3% nuclear fast red. Induction of
aggrecan mRNA by TGF-1 was assessed in the protocol
as follows. CL-1 cells were plated on 60-mm culture dishes
(CORNING) in 10% FCS/-MEM. After confluence, 15 ng
TGF-1 was daily added into the culture medium for
7 days. In the control culture, 50 µl PBS was added daily.
Expression of aggrecan mRNA was examined by RT-PCR
as described above.
ADIPOGENESIS MORPHOMETRY
Adipogenesis was measured by microscopic morpho-
metry (imaging system KS300, release 2.0, KONTRON
ELEKTRONIK GmbH, Mu¨nchen, Germany). CL-1 cells
were plated on 4 wells chamber slides (2.5×103 cells/cm2).
After cells reached confluence, cells were treated with
10%FCS/-MEM (control), 100 nmol/l VD3, 100 nmol/l
ATRA, 10 ng/ml TGF-1, 100 ng/ml IGF-I for 3 weeks after
confluence. Cell layers were stained with alcian blue pH 1.0
and oil red O as described. Fifteen fields were selected
randomly under a ×20 objective lens for the measurement.
Oil red O positive area was measured in the threshold RGB
mode, at the following color intensity ranges: red 101–187,
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green 30–115, and blue 22–133. After binarization, the
signal area was summarized as the oil red O positive area.
The fractional oil red O positive area was calculated by
following formula:
Fractional oil red O positive area (FOPA,%)=oil red O
positive area/total area ×100
Effects of described factors on FOPA were examined by
the ratio to the mean FOPA of individual controls.
OSTEOGENICITY OF CL-1
To assess the osteogenicity of CL-1, mRNA expression
of specific marker proteins for osteoblasts (Runx2 and
Osterix) was examined by RT-PCR. CL-1 cells (2.5×103
cells/cm2) were plated on 60-mm plastic dishes (CORN-
ING) in control medium (10% FCS/-MEM) for 7 days. CL-1
cells were also treated with dexamethasone (10 nmol/l,
Sigma) or recombinant human BMP-2 (100 ng/mL,
STRATHMANN BIOTECH GMBH, Hanover, Germany) for
7 days in 10% FCS/-MEM. Three and 7 days after plating,
total RNA was extracted by ISOGEN (Nippon Gene,
Tokyo). Expression of mRNA of the osteogenic transcrip-
tion factors (Runx2 and Osterix) was examined by RT-PCR
as previously described.
STATISTICAL ANALYSIS
All statistical analyses were performed with SAS (SAS
institute, Tokyo, Japan). Significance was set as P<0.05.
Results
CELL MORPHOLOGY AND MINERALIZATION
CL-1 revealed polygonal cell morphology in growing
phase (Fig. 1A). After confluence, CL-1 formed cartilage
nodules, which were positive for alcian blue pH 1.0. All of
the nodules were positive for alcian blue pH 1.0 (Fig. 1B).
On the other hand, after confluence, CL-1 differentiated
also into adipocytes, which have oil red O lipid droplets
within their cytoplasm. Adipocytes were observed in inter-
nodular regions, and were negative for alcian blue pH 1.0
(Fig. 1B). ALP activity of CL-1 increased in a confluent-
dependent manner (Fig. 1C). The cartilage nodules formed
by CL-1 cells were mineralized in the presence of ascorbic
acid and -glycerophosphate, and they were positive for
alizarin red S (Fig. 1D). Ca content in cell layer of CL-1
drastically increased to after 3 weeks culture in 60-mm
culture dishes (control medium: 263±6.3 µg/dish, mineral-
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Fig. 1. Cell morphology, nodule formation and mineralization of CL-1 cells. A: Polygonal shape of CL-1 in growing phase (original
magnification: ×100). B: Cartilage-like nodules and adipocytes formed by CL-1. Three weeks after confluence, 10% FCS/-MEM. Double
staining of alcian blue pH 1.0 and oil red O counter stained by 0.3% nuclear fast red. Original magnification: ×30. C: Alkaline phosphatase
(ALP) activity of CL-1. Upper panel: Heterogeneous ALP activity was observed at sparse confluency. Lower panel: Elevated ALP activity at
confluence was observed. Heterogeneous staining pattern was remained. ALP activity was detected by naphtol AS-BI as substrate and Fast
Blue RR as coupler. Counter staining: 0.3% nuclear fast red. Original magnification: ×50. D: Mineralization of CL-1. Cartilage-like nodules
were mineralized in the presence of ascorbic acid and -glycerophophate. Upper wells: medium only (10% FCS/-MEM). Lower wells:
medium containing L-ascorbic acid (50 µg/mL) and -glycerophophate (10 mmol/L). Four weeks after confluence. Alizarin red S staining.
E: Ultramicrostructure of CL-1 inside cartilage-like nodule. CL-1 has well developed rough endoplasmic reticulum, small lipid droplet (arrow)
and glycogen granules (arrowhead). Many matrix vesicles were observed in extracellular matrix. This matrix contains fine collagen fibers and
high electron density granules suggesting collagen type II and proteoglycans, respectively. Four weeks after confluence. Original
magnification: ×5000. F: High power magnification of matrix vesicles and deposited mineral. Many matrix vesicles (arrow) were observed in
extracellular matrix of the nodule. Shape of mineral crystals (arrowhead) was similar as that of normal mineralized cartilage. Original
magnification: ×30 000.
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ization medium: 820±5.2 µg/dish, mean±SD, P<0.01,
Student t-test). The ratio of Ca/Pi in the mineralized cell
layer was 1.65±0.02 (mean±SD). Transmission electron-
microscopy demonstrated that CL-1 cells have a similar
ultrastructure to that of chondrocytes, namely well-
developed rough endoplasmic reticulum, many glycogen
granules, and minute cytoplasmic lipid droplets (Fig. 1E).
Extracellular matrix (ECM) was composed of fine collagen
fibers and minute high electron density granules suggest-
ing proteoglycans. ECM contained many matrix vesicles
and mineral deposition (Fig. 1F). Mineral crystals in ECM
had a similar ultramicrostructure to that of the primary
chondrocyte culture17.
CL-1 formed cartilage nodules and differentiated into
adipocytes after 50 passages, demonstrating the stable
bipotent phenotype of this cell line. The clonality was
assessed by subcloning of CL-1. Thirty-nine of forty sub-
clones of CL-1 had bipotency in vitro, namely, they differ-
entiated into chondrocytes and adipocytes. One of forty
subclones differentiated only into adipocytes. These data
suggested the clonality of CL-1.
RT-PCR
Expression of marker proteins mRNA for chondrocytes
and adipocytes is shown in Fig. 2. In the early phase of
growth (1 and 3 days after plating), mRNA of specific
markers of chondrocytes (collagen type II or X) was not
expressed. At 7 days after plating, mRNA of collagen
type II and X was detected. On the other hand, PPAR-2
mRNA was not detected in CL-1 cells 7 days after plating
(Fig. 2A).
Collagen type II and X mRNA were expressed also at
10 days after plating (subconfluence) and 1–3 weeks after
confluence. Aggrecan mRNA was expressed very slightly
at subconfluence and 1 week after confluence, and
then evidently expressed 2 and 3 weeks after confluence.
Collagen type I mRNA was slightly expressed 1 and
2 weeks after confluence. Both Ihh and BMP-2 mRNA were
constantly expressed in the culture period examined.
PPAR-2 mRNA was detected from 1 week to 3 weeks after
confluence with evident expression 1 week after conflu-
ence. Expression of aP2 mRNA was detected after the
peak expression of PPAR-2, namely from 2 to 3 weeks
after confluence. Expression of these adipocytic genes
correlated with accumulation of lipid droplets within the
cytoplasm of CL-1 cells. Beta-actin mRNA was detected at
a similar intensity at all examined points (Fig. 2B).
IMMUMOCYTOCHEMISTRY
Photomicrographs of immunocytochemistry for collagen
type II, X, or I are shown in Fig. 3. Collagen type II (Fig. 3A),
X (Fig. 3B) or I (Fig. 3C) was positively stained in CL-1 cells
within nodules. All nodules CL-1 formed were positive for
collagen type I, II, and X. Non-immunized rabbit IgG, a
negative control, showed no specific staining pattern
in CL-1 cells (Fig. 3D). Adipocytes were negative for
collagens examined (Fig. 3A–C).
TRANSPLANTATION OF CL-1 INTO SCID MICE
CL-1 cells were subcutaneously transplanted into the
back of SCID mice to examine the potency of differentiation
in vivo. Four weeks after transplantation, cartilage, primary
spongiosa, bone marrow, and adipose tissue were histo-
logically observed in the transplant of CL-1 cells (Fig. 4A).
Fig. 2. Expression of mRNA of specific marker proteins for chondrocytes and adipocytes in CL-1 (RT-PCR). Marker proteins of chondrocytes
and adipocytes were expressed in CL-1. A: Examination in the early phase of growth. B: Examination in subconfluent and after confluence.
Col I: collagen type I, Col II: collagen type II, Col X: collagen type X, Ihh: Indian Hedgehog. S: subconfluent (10 days after plating), 1–3: 1–3
weeks after confluence, respectively. Amplification: 32 cycles. No band was detected in RT (-) controls (data not shown).
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Cartilage had the features of hyaline cartilage, namely,
abundant homogeneous extracellular matrix which showed
metachromasia for toluidine blue (pH 7.0, Fig. 4B). Hyper-
trophic chondrocytes were observed in the cartilage formed
by transplanted CL-1 cells. Cartilage formed by CL-1
was replaced by primary spongiosa and bone marrow.
Clustered adipocytes were occasionally observed within
abundant fibroblastic cells with no specific differentiation
(Fig. 4C). On the other hand, transplanted NIH3T3 cells
revealed only a fibroblastic histological feature. This cell
line showed no specific differentiation in this transplantation
(Fig. 4D). These histological findings demonstrated the
bipotency of CL-1 cells into chondrogenic and adipogenic
lineages in vivo.
EFFECTS OF GROWTH FACTORS OR HORMONES ON THE GROWTH
OF CL-1
Results were shown in Fig. 5. TGF-1 suppressed
3H-thymidine uptake of CL-1 cells at 1 and 10 ng/ml. VD3(10, 100 nmol/l), ATRA (100 nmol/l), and bFGF (10 ng/mL)
also suppressed growth of CL-1 cells in the presence of
20% FCS. On the other hand, IGF-I stimulated growth at
100 ng/ml in the presence of 3% FCS. PTH (1-34) did not
change 3H-thymidine uptake in examined concentrations
neither in the presence of 3% (Fig. 5) nor 20% FCS (data
not shown).
EFFECTS OF GROWTH FACTORS OR HORMONES ON THE
DIFFERENTIATION OF CL-1
Photomicrographs of double staining (alcian blue pH1.0
and oil red O) of CL-1 cells treated with several growth
factors or hormones at 3 weeks after confluence are shown
in Fig. 6. Effects of examined growth factors and hormones
on the chondrogenesis in CL-1 cells were assessed by
alcian blue intensity (Fig. 7).
TGF-1 markedly increased the frequency of chondro-
cytes and alcian blue intensity in CL-1 at 1.0 and 10 ng/mL
(Fig. 6B, Fig. 7). Simultaneously, TGF-1 markedly sup-
pressed the frequency of adipocytes and FOPA (Fig. 6B,
Fig. 9). Fifteen ng of TGF-1 was daily added into the
culture medium of the CL-1 cell culture in 60-mm culture
dishes for 7 days after confluence. This treatment induced
marked induction of aggrecan mRNA in CL-1 cells (Fig. 8).
These data demonstrated that TGF-1 induced dominant
chondrogenic commitment and suppressed adipogenic
commitment in CL-1 when this growth factor was added
after CL-1 cells reached confluence.
IGF-I did not induce dominant chondrogenesis in CL-1
when added after CL-1 cells reached confluence. However,
IGF-I increased both alcian blue intensity and FOPA in
CL-1 cells (Fig. 6C, Fig. 7, Fig. 9) in the presence of 10%
FCS. Although IGF-I did not stimulate the cell growth of
CL-1 cells in the presence of 10% FCS (data not shown),
IGF-I stimulated the growth of CL-1 cells in the presence of
3% FCS (Fig. 5).These data suggest that IGF-I stimulates
the accumulation of cartilage matrix and cytoplasmic lipid
droplets in CL-1 cells.
VD3 intensely inhibited both chondrogenesis and
adipogenesis in CL-1 cells at 10 and 100 nmol/l (Fig. 6D,
Fig. 7, Fig. 9). Since CL-1 cells stayed in monolayer just
after the addition of VD3 at 10 or 100 nmol/l, nodule
formation of CL-1 cells was completely blocked during the
3 weeks culture after confluence.
ATRA intensely inhibited both chondrogenesis and
adipogenesis in CL-1 at 100 nmol/l (Fig. 6E, Fig. 7, Fig. 9).
In the presence of this concentration of ATRA, the cell
shape of CL-1 was changed into a spindle (Fig. 6E).
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Fig. 3. Immunocytochemistry for marker proteins of chondrocytes. Marker proteins of chondrocytes (A: collagen type II, B: collagen type X)
were detected in the nodules formed by CL-1 cells by immunocytochemistry (brown signal). C: collagen type I, D: control rabbit IgG. White
arrowheads: chondrocytes which were stained positively for individual primary antibody. Arrow: adipocytes (negative for all examined primary
antibodies). Counter staining: Mayer’s haematoxylin. Original magnification: ×80
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PTH (1-34) slightly suppressed the alcian blue intensity
at 1 and 2 weeks after confluence. However, this tendency
ceased at 3 weeks after confluence.
Basic FGF treatment tends to suppress the alcian blue
intensity at 1 week after confluence in 0.1 and 10 ng/mL.
However, this tendency ceased at 2 and 3 weeks after
confluence.
OSTEOGENICITY OF CL-1
To examine the osteogenicity of CL-1 in monolayer
culture, mRNA expression of osteogenic transcription
factors was examined by RT-PCR (Fig. 10). Messenger
RNA of neither Runx2 nor Osterix was expressed in control
medium (10% FCS/-MEM). On the other hand, dexam-
ethasone (10 nmol/l) or BMP-2 (100 ng/ml) treatment for
7 days induced a slight expression of Runx2 and Osterix
mRNA. Dexamethasone or BMP-2 did not alter the
expression level of -actin mRNA.
Discussion
A bipotent cell line CL-1, which spontaneously differen-
tiates into chondrocytes and adipocytes, was established
from tibia of a normal adult mouse.
CL-1 formed cartilage-like nodules in a monolayer cul-
ture. All of nodules were positive for alcian blue (pH 1.0).
In the early phase of growth, CL-1 did not express
specific markers of chondrocytes (collagen type II, X) and
adipocytes (PPAR-2). At 7 days after plating, mRNA of
collagen type II and X was expressed in CL-1 cells. These
data demonstrated that the commitments of CL-1 into
chondrocytic or adipocytic lineages were diminished in the
early phase of growth.
Collagen type II and X mRNA were expressed also at
subconfluence (at 10 days after plating) and 1-3 weeks
after confluence. Aggrecan mRNA was expressed slightly
at subconfluence and 1 week after confluence, and then
expressed 2 and 3 weeks after confluence. Collagen type I
mRNA was slightly expressed 1 and 2 weeks after conflu-
ence. Proteins of collagen type I, type II and type X were
detected in immunostaining. These demonstrated that CL-1
differentiates into chondrocytes in vitro. The expression of
collagen type I at a later phase coincided with the growing
phase of cartilage nodules. Collagen type I might express
in the expanding phase of cartilage nodules of CL-1.
Constant expression of Ihh and BMP-2 mRNA during
nodule formation may suggest that chondrogenesis of CL-1
is regulated by these chondrogenesis regulating growth
factors18. CL-1 showed evident ALP activity at high cell
Fig. 4. Differentiation of CL-1 cells and NIH3T3 cells in subcutis of SCID mouse at 4 weeks after transplantation. A: Hyaline cartilage
formation in the site of CL-1 cells transplantation (arrow). Hypertrophic chondrocytes were also observed. Primary spongiosa (arrowhead)
was also formed with contiguous bone marrow (BM). Haematoxylin and eosin staining. Original magnification: ×100. B: Toluidine blue pH 7.0
staining of hyaline cartilage in the site of CL-1 cells transplantation. Hyaline cartilage showed metachromasia to toluidine blue pH 7.0 (arrow).
Hypertrophic chondrocytes were also observed. Primary spongiosa (arrowhead) was also formed with contiguous bone marrow (BM).
Original magnification: ×100. C: Adipose tissue within transplanted CL-1 cells. Clustered adipocytes were scattered in abundant fibroblastic
cells. Haematoxylin and eosin staining. Original magnification: ×80. D: Histological appearance of transplanted NIH3T3 cells, No specific
differentiation was observed throughout the transplanted cells. Haematoxylin and eosin staining. Original magnification: ×80.
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confluency, and nodules were mineralized by ascorbic
acid and -glycerophosphate. The ratio of Ca and Pi
(1/65±−0.2) of deposited mineral in cartilage nodules
formed by CL-1 was similar to that of hydroxyapatite,
1.6717. These data demonstrated that CL-1 differentiates
into terminal differantiation of chondrocytes in vitro, namely
hypertrophy and mineralization1.
CL-1 differentiates also into adipocytes in a monolayer
culture. Expression of mRNA of PPAR-2, a master regula-
tor gene of adipocytic differentiation, was detected 1 week
after confluence. And then, aP2 mRNA was expressed.
These genes were expressed following the expression of
the chondrocytic genes. Earlier expression of collagen type
II, X and aggrecan than PPAR-2 might suggest that the
chondrogenic commitment occurs first in CL-1 followed by
adipogenic commitment.
Hyaline cartilage and adipose tissue were formed within
transplanted CL-1 cells into subcutis of SCID mice. Since
the hyaline cartilage showed metachromasia for toluidine
blue, it is suggested that its extracellular matrix contain a
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Fig. 5. Effect of growth factors and hormones on the growth of CL-1 cells. [3H] thymidine (0.1 µCi/well) uptake for 6 h was measured after
treatment by growth factors or hormones for further 6 hours. FCS concentration for TGF-1, VD3, ATRA, bFGF, PTH (1-34): 20%, IGF-I: 3%.
TGF-1, VD3, ATRA and bFGF suppressed [3H] thymidine uptake of CL-1 cells in 20% FCS/-MEM. IGF-I stimulated [3H] thymidine uptake
of CL-1 cells in 3% FCS/-MEM. *P<0.05, **P<0.01: Significant difference from control (Student t-test).
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substantial amount of proteoglycans. Chondrocytes within
the transplanted CL-1 cells differentiated into hypertrophic
chondrocytes and replaced by primary spongiosa. Although
the exact origin of the primary spongiosa is unclear, it
might be derived from SCID mouse because bone marrow
was also formed contiguously to the primary spongiosa.
There is no direct evidence whether the origin of the
chondrocytes and adipocytes within transplanted site is
transplanted CL-1 cells. However, this is presumed
because transplanted NIH-3T3 cells revealed no specific
differentiation. In diffusion chamber transplantation19, CL-1
did not proliferate within the chamber (data not shown).
High auxotrophy of CL-1 cells will disturb this analysis. To
examine the bipotency of CL-1 in the SCID mouse trans-
plantation system directly, transplantation of reporter
gene transfected CL-1 cells into SCID mice should be
performed.
TGF-1 induced dominant chondrogenesis and marked
suppression of adipogenesis in CL-1 when added after
confluence. In osteogenic commitment, inductive dominant
commitment into osteoblasts by BMP-2 was reported in
multipotent mesenchymal cell line ROBC2610 or C2C12
myoblast15. These cell lines have been used useful tools in
osteogenic commitment in vitro. These data will suggest
that CL-1 can be a useful tool for the elucidation of the
regulatory mechanisms of chondrogenic commitment in
multipotent mesenchymal cells in adult animal.
IGF-I had a stimulating effect on the cell growth of CL-1
(in 3% FCS), and an anabolic effect on the accumulation of
extracellular matrix in chondrocytes and cytoplasmic lipid
droplets in adipocytes (in 10% FCS). Stimulating effect of
IGF-I on DNA synthesis was reported in many types of cells
including chondrocytes, adipocytes, osteoblasts or multi-
potent mesenchymal cells20–23. Similar to these cells, IGF-I
stimulated cell growth of CL-1 in the presence of 3% FCS,
but this effect was not observed in the presence of 10%
FCS. This data suggests that the stimulating effect of IGF-I
on the cell growth of CL-1 is negligible in the anabolic effect
of IGF-I on the accumulation of extracellular matrix in
chondrocytes and cytoplasmic lipid droplets in adipocytes.
This might suggest that the anabolic effect of IGF-I is based
on the stimulating effect on the ECM deposition and lipid
droplet accumulation in committed CL-1 cells into chondro-
genic and adipogenic lineages in the presence of 10%
FCS. Since the anabolic activities of TGF-1 and IGF-I
on the chondrogenesis were clearly detected by CL-1,
CL-1 will be a useful tool for in vitro screening tool for
chondrogenic agents.
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Fig. 6. Effect of growth factors and hormones on the differentiation of CL-1 cells. A: Control medium (10% FCS/-MEM). B: TGF-1(10 ng/mL). C: IGF-I (100 ng/mL). D: VD3 (100 nmol/L). E: ATRA (100 nmol/L). TGF-1 induced dominant chondrogenesis and apparent
suppression of adipogenesis. IGF-I stimulated both chondrogenesis and adipogenesis of CL-1. VD3 evidently suppressed both of
chondrogenesis and adipogenesis in CL-1. ATRA also inhibited both of chondrogenesis and adipogenesis in CL-1, cell shape was changed
into spindle. CL-1 cells were treated by growth factors or hormones for three weeks after confluence in 4 well chamber slides. Double
staining of alcian blue (pH 1.0) and oil red O counterstained by 0.3% nuclear fast red. Original magnification: ×60.
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Both VD3 and ATRA inhibited proliferation, chondro-
genesis and adipogenesis in CL-1. Inhibitory effects of VD3
and ATRA on chondrogenesis and adipogenesis were
reported in vitro13,24–28. These findings suggested that
VD3 and ATRA acted on CL-1 as negative regulators of
growth and differentiation both in chondrogenesis and
adipogenesis.
Basic FGF slightly inhibited growth of CL-1 in the
presence of 10% FCS. Mitogenic activity of bFGF in
mesenchymal cells including chondrocytes, chondro-
progenitor cell line and multipotent mesenchymal stem has
been reported29–31. On the other hand, inhibitory effects of
FGF signaling on chondrogenesis were also reported in
bFGF overexpression mouse or organ culture of metatarsal
Fig. 7. Effects of growth factors and hormones on the chondrogenesis of CL-1 cells. TGF-1 increased the alcian blue intensity of CL-1 cells
in dose dependent manner. IGF-I also increased the alcian blue intensity of CL-1 cells at 100 ng/mL. VD3 and ATRA inhibited
chondrogenesis of CL-1. PTH (1-34) and bFGF slightly suppressed the alcian blue intensity at early phase of culture. **P<0.01: Significant
difference from control (Student t-test).
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bone rudiment, relating to achondroplasia32–35. The activity
of bFGF in CL-1 might be corresponding to the latter
activities in chondrogenesis.
PTH (1-34) suppressed the chondrogenesis in the early
stage of differentiation in CL-1, and then this effect ceased
in the later stage. Since PTH (1-34) did not alter growth
in CL-1 cells in the presence of 10% FCS, inhibitory
effect of PTH (1-34) at early stage will not be according
to the growth inhibition by PTH (1-34). Although the
anabolic activities of PTH (1-34) in chondrocytes were
reported16, the inhibitory effect of PTH (1-34) was reported
in ATDC-5 both in the early and late stage of chondrogen-
esis via PTH/PTHrP receptor36,37. A similar effect of PTH
(1-34) might occur also in the early stage of differentiation
in CL-1 cells. However, the mechanisms of the recovery in
the chondrogenesis of CL-1 cells in the presence of PTH
(1-34) remains to be elucidated.
The alcian blue intensity of CL-1 cells in control cultures
slightly increased in a culture term dependent manner. This
will indicate the accumulation of cartilage matrix in
Aggrecan
β-actin
CNT TGF-β1
Fig. 8. Induction of aggrecan mRNA by TGF-1 treatment in CL-1
cells. Daily addition of TGF-1 for 7 days after confluence induced
aggrecan mRNA. Aggrecan mRNA was not detected in control
culture (CNT). After CL-1 cells reached confluence, 15 ng of
TGF-1 was daily added for sequential 7 days into 15 mL culture
medium of CL-1 monolayer cultures in 60 mm culture dish. In
control culture, 50 µL (equal volume of that of TGF-1 addition)
PBS was daily added into the medium. Expression of aggrecan
mRNA was examined by RT-PCR in 32 cycles.
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Fig. 9. Effects of growth factors and hormones on adipogenesis of CL-1 cells. Adipogenesis of CL-1 cells were measured by morphometry
of fractional oil red O positive area (FOPA, % of total measured area) after three weeks treatment by growth factors or hormones. ATRA
(1 mol/L), VD3 (100 nmol/L), TGF-1 (10 ng/mL) almost completely suppressed the adipogenesis of CL-1 cells. IGF-I (100 ng/mL) stimulated
the adipogenesis of CL-1 cells. **P<0.01: Significant difference from control (Student t-test).
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Fig. 10. Expression of Runx2 and Osterix mRNA in CL-1 in the presence of dexamethasone or BMP-2. CL-1 cells were plated on 60-mm
dishes in 2.5×103 cells/cm2 in 10% FCS/-MEM. Total RNA was extracted after 3 and 7 days treatment by dexamethasone (10 nmol/L) or
rhBMP-2 (100 ng/mL). Very slight expression of Runx2 and Osterix mRNA was induced by dexamethasone and BMP-2 in CL-
1.Amplification: 32 cycles. No band was detected in RT (-) controls (data not shown).
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cartilage-like nodules. However, this tendency was not
observed in the control culture of bFGF treatment. The
cause of this difference is still not clear. Therefore, improve-
ment of the measurement protocol of alcian blue intensity
might be needed to establish an assay system with a stable
base line.
The exact source of CL-1 within tibia is not clear because
the entire proximal region of the tibia was cultured after
rough bone marrow removal. Bone marrow will be the most
likely source of CL-1 because multipotent mesenchy-
mal cells in bone marrow are reported38–41. However,
periosteum can be also the origin of CL-1 because its
multipotency was reported42,43.
Establishment of CL-1 will be an example of bipotent
progenitor of chondrocytes and adipocytes in adult animal.
On the other hand, a quadripotential mesenchymal cell line
was established from SV40 large T antigen transgenic
mouse44, which demonstrates the existence of mesenchy-
mal stem cell in bone marrow of adult mouse. Establish-
ment of these cell lines will suggest that the lineage
restriction45 in mesenchymal stem cells takes place in adult
mouse.
CL-1 did not express mRNA of Runx2 and Osterix,
specific markers for osteoblasts in control culture. On the
other hand, dexamethasone and BMP-2 induced slight
mRNA expression of these proteins. These data suggest
that CL-1 is not osteogenic spontaneously, but exogenous
stimulation like dexamethasone or BMP-2 induces the
osteogenicity of CL-1. Further investigations should be
performed to clarify the osteogenicity of CL-1.
In conclusion, adult mouse derived bipotent chondro-
progenitor cell line CL-1 will be a useful tool in elucidation
of the chondrogenic commitment in multipotent mesenchy-
mal cells in adult animal and screening of chondrogenic
agents for cartilage regeneration.
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